meRfi®-GM
Alzheimer’s Disease (AD) & Dysbiosis
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Differential abundance analysis identified 14 OTUs that were increased and 68 OTUs that were decreased in Alzheimer’s Disease (AD) relative to Control
In Alzheimer’s disease increases in Rikenellaceae and a decrease in Allobaculum and Akkermansia were determined
Dysbiosis can increase the secretion of lipopolysaccharides and [bacterial amyloids](brain://4Gts6GQj2ki6gcOpedB1Ww/AlzheimersDiseas…
References (Sources)
- Antibiotic-induced perturbations in gut & microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease.
- Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
- Brain-Gut-Microbiota Axis in Alzheimer’s DiseaseReview
- Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation StrategiesReview
- Gut microbiome alterations in Alzheimer’s disease
- Gut microbiota is altered in patients with Alzheimer’s disease
- The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis